Peroxisome proliferator-activated receptor-  activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in Type 2 diabetes

Activation of Peroxisome Proliferator–Activated Receptor δ Inhibits Streptozotocin-Induced Diabetic Nephropathy Through Anti-Inflammatory Mechanisms in Mice

(2011) Yuichi Matsushita et al.   DIABETES

The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury

(2010) Gianluca Miglio et al.   BRITISH JOURNAL OF PHARMACOLOGY

Modulation of Notch-1 Signaling Alleviates Vascular Endothelial Growth Factor–Mediated Diabetic Nephropathy

(2010) Chun-Liang Lin et al.   DIABETES

The Decreased Expression of Peroxisome Proliferator-activated Receptors δ (PPARδ) is Reversed by Digoxin in the Heart of Diabetic Rats

(2010) S. C. Fan et al.   HORMONE AND METABOLIC RESEARCH

Improved insulin sensitivity and islet function after PPARδ activation in diabetic db/db mice

(2009) Maria Sörhede Winzell et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

PPAR-δ senses and orchestrates clearance of apoptotic cells to promote tolerance

(2009) Lata Mukundan et al.   NATURE MEDICINE

PPAR -mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis

(2008) Y. Takata et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA